Strong 2025-26 for Fletchers following revenue growth and accelerated profitability

Commenting on the accounts, which cover May 2025 to April 2026, Alex Lynch, CFO, said the result told a “strong story of significant revenue growth, a substantial increase in underlying profitability and continued investment in scaling up the business.”

She explained that the 2026 accounts included £6.5m of exceptional costs, while 2025 benefited from a net exceptional credit of £4.0m, largely arising from the one-off release of an £8.2m trade creditor balance. Although reported EBITDA was £11.5m, adjusting for these exceptional items brought underlying EBITDA to £18.0m (2025: £7.0m).

Average employee numbers grew from 791 to 1,160, reflecting both organic growth and acquisitions.

During the 2025-26 financial year, Fletchers acquired Shoosmiths’ Serious Injury practice, family law specialist Rayden Solicitors and Court of Protection specialists EMG Solicitors and JE Bennett Law.

Fletchers also strengthened its leadership, expanding the Executive Committee to include Emma Gaudern, CEO of EMG Solicitors, Katherine Rayden, CEO of Rayden Solicitors, and Miriam Hall, Managing Director of Operational Excellence. Women now make up two-thirds of the committee.

Since the year end, Fletchers Solicitors has also added Freeths’ clinical negligence practice, while Freeths’ Court of Protection business has joined EMG Solicitors within the wider group. The acquisition of Moore Barlow’s personal injury and clinical negligence teams and Aspire Law is expected to complete on 1 November. This will take colleague numbers at Fletchers Solicitors to more than 1,500.

Alex said the decision by investor Sun Capital to secure its long-term backing via a continuation fund investment will enable Fletchers Solicitors and the wider group of companies to continue to invest and grow under their current ownership into the 2030s.

“That backing and support from our investor will enable us to pursue our long-term strategy for organic growth and further M&A, strengthening our core personal injury and clinical negligence practice while also building a stronger presence in family law following the acquisition of Raydens last year.”

Looking ahead Alex said, she was confident that the momentum generated during the last year would continue supported by ongoing organic growth and further opportunities for selective acquisitions across Fletchers Solicitors and the wider group of companies.

She added that Fletchers is also keen to play an industry-leading role in supporting moves to bring down the costs of clinical negligence, while working with stakeholders to improve outcomes for injured people.

“Although since 2018/19 the estimated cost of harm has been broadly flat or falling in real terms, despite a 20% increase in NHS activity, we believe it is incumbent on all stakeholders to work together to reduce the incidence of clinical negligence, especially in maternity, and improve the outcomes for families who’ve been harmed.”

She cited the collaborative work between NHS Resolution and Fletchers, through stocktaking and Joint Settlement Meetings, as one reason why the costs of harm have stabilised and legal fees remained flat. “We are proud of the joint initiatives we have set up with NHSR, that have made substantive improvements to outcomes of negligence cases.”